The France Mental Health Screening Market was valued at $14.47 Million in 2023 and projected to reach to $29.07 Million by 2028, representing a compound annual growth rate of 12.3%. France's mental health screening market is positioned for robust growth through 2028, driven by government initiatives prioritizing mental health infrastructure and early intervention strategies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
France's mental health screening market reached $14.47 million in 2023 and is expected to grow to $29.07 million by 2028, doubling in size over the five-year forecast period.
The French market is expanding at a 12.3% CAGR, slightly outpacing the global average of 12.2%, indicating France's accelerating adoption of mental health screening solutions.
France is significantly increasing investment in mental health infrastructure and early intervention programs, driving demand for advanced screening tools and diagnostic technologies.
Heightened public awareness of mental health issues and workplace wellness initiatives are fueling demand for screening tools across healthcare facilities, corporate sectors, and community health centers in France.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | COGNITIVE (Application) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 12.2% from 2023 to 2028 |
| Largest Segment | ADULTS (AGE 19-64 YEARS) (Age Group) |
| Market Size Base Year (Billions) | ~USD 0.9 (2023) |
| Revenue Forecast (Billions) | ~USD 1.6 (2028) |
| Segments Covered | Application, Type, Screening Method, Technology, Age Group, Setting |
6 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BEHAVIORAL DISORDERS | 5.19 | 5.8 | 6.51 | 7.33 | 8.28 | 9.4 | 10.72 | 12.27 | 13.3 |
| COGNITIVE DISORDERS | 3.97 | 4.46 | 5.03 | 5.69 | 6.46 | 7.37 | 8.45 | 9.72 | 13.9 |
| PHYSIOLOGICAL DISORDERS | 13.05 | 14.47 | 16.09 | 17.96 | 20.12 | 22.65 | 25.6 | 29.07 | 12.3 |
| PSYCHIATRIC DISORDERS | 8.54 | 9.34 | 10.25 | 11.28 | 12.48 | 13.85 | 15.45 | 17.3 | 10.8 |
| TOTAL | 30.76 | 34.07 | 37.88 | 42.26 | 47.34 | 53.27 | 60.22 | 68.37 | 12.3 |
France's mental health screening market was valued at $14.47 million in 2023.
France's mental health screening market is projected to reach $29.07 million by 2028.
France's mental health screening market is growing at a compound annual growth rate of 12.3% from 2023 to 2028.
Growth in France is driven by increased mental health awareness, government initiatives for primary care integration, digital health adoption, and regulatory support for mental health parity.
France represents a significant market within Europe, with strong government support and healthcare system integration contributing to above-average growth rates in the region.
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Mental Health Screening market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Agency for Healthcare Research and Quality (AHRQ), Primary Care Companion for CNS Disorders Journal, Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Expert Interviews, and MarketsandMarkets Analysis.
Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Note 1: Tiers are defined based on the total revenues of companies. As of 2022, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The total size of the mental health screening market was arrived at after data triangulation from various approaches, as mentioned below. After completing each approach, a weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Separate research approaches were followed to estimate the revenue from mental health screening tools and continuous monitoring wearable devices used for mental health screening.
After arriving at the overall market size, from the market size estimation process explained above, the Mental Health Screening market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Mental Health Screening market.
Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided.
Screening tools may include questionnaires, surveys, or interviews that assess various aspects of an individual’s mental health, such as mood, behavior, thoughts, and emotions. These screenings are often administered by healthcare professionals, counselors, or mental health providers in different settings, including schools, workplaces, clinical settings, and others.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Mental Health Screening Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report